Immuron Ltd ADR (IMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMRN | AZN | AMGN | GILD | VRTX |
| Company | Immuron Ltd ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.8200 | 193.91 | 373.51 | 145.11 | 489.97 |
| High | 0.8200 | 193.92 | 375.00 | 145.76 | 489.97 |
| Low | 0.8200 | 191.95 | 368.50 | 144.02 | 483.83 |
| Latest | 0.8200 | 193.32 | 373.10 | 145.31 | 487.13 |
| Change | unch | +0.01 | -4.54 | -0.69 | -5.25 |
| % Change | unch | +0.01% | -1.20% | -0.47% | -1.07% |
| Volume | 182 | 203,011 | 106,077 | 217,842 | 49,761 |
| 20-Day Average Volume | 22,089 | 1,972,351 | 2,462,803 | 6,524,335 | 1,437,734 |
| Previous Close | 0.8200 | 193.31 | 377.64 | 146.00 | 492.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7747 | 202.24 | 376.65 | 148.75 | 478.60 |
| 20-Day Raw Stochastic | 65.31% | 11.47% | 32.00% | 8.89% | 60.24% |
| 20-Day Relative Strength | 47.44 | 45.93 | 53.28 | 50.92 | 53.85 |
| Weighted Alpha | -55.47 | +28.40 | +26.13 | +35.06 | +4.34 |
| Today's Opinion | 80% Sell | 56% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 80% Sell | 64% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.13% since 03/05/26 | -2.78% since 03/05/26 | +0.91% since 03/05/26 | -0.76% since 03/05/26 | +5.28% since 03/05/26 |
| Low | 0.7500 on 03/06/26 | 189.35 on 03/09/26 | 361.70 on 03/06/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 0.8943 on 03/11/26 | 198.09 on 03/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 507.92 on 03/10/26 |
| 1-Month | |||||
| %Chg | +16.58% since 02/12/26 | -6.11% since 02/12/26 | +1.30% since 02/12/26 | -5.12% since 02/12/26 | +4.33% since 02/12/26 |
| Low | 0.6900 on 02/20/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 0.8943 on 03/11/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.95 on 02/13/26 | 507.92 on 03/10/26 |
| 3-Month | |||||
| %Chg | -19.61% since 12/12/25 | +6.89% since 12/12/25 | +16.75% since 12/12/25 | +19.63% since 12/12/25 | +7.33% since 12/12/25 |
| Low | 0.6765 on 12/30/25 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 1.2500 on 01/14/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | -57.51% since 09/12/25 | +20.68% since 09/12/25 | +34.22% since 09/12/25 | +25.74% since 09/12/25 | +22.97% since 09/12/25 |
| Low | 0.6765 on 12/30/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 2.3900 on 10/16/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,696 | 299,806,016 | 203,573,632 | 181,247,456 | 125,081,264 |
| Shares Outstanding, K | 8,166 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 4,720,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -3,380,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 0.85 | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 10/07/25 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.29 | 17.18 | 18.23 | 30.40 |